Reviews Book

The $800 Million Pill: The Truth Behind the Cost of New Drugs

BMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7465.577 (Published 02 September 2004) Cite this as: BMJ 2004;329:577
  1. Jeff Aronson, reader in clinical pharmacology (jeffrey.aronson@clinpharm.ox.ac.uk)
  1. Oxford

    Two sets of statistics summarise the two main preoccupations of this book.


    Embedded Image

    Merrill Goozner

    University of California Press, $24.95/£16.95, pp 297 ISBN 0 520 23945 8 Also available as a digital download www.ucpress.edu/

    Rating: GraphicGraphic

    Firstly, the costs of drug development. The Tufts University Center for the Study of Drug Development calculated that in 2001 the pharmaceutical industry spent $802m (£446m; €663m) per marketed drug, while the Global Alliance for TB Drug Development thought that a new antituberculosis drug could be developed in the public sector for as little as $115m to $240m, conceding that the international …

    View Full Text

    Sign in

    Log in through your institution

    Subscribe